Candidiasis, Oral Clinical Trial
Official title:
A Phase 3, Randomized, Double-Blind, Comparative Trial of Two Dosing Regimens of Micafungin (FK463) Versus Caspofungin for the Treatment of Esophageal Candidiasis
To determine the efficacy and safety of daily doses of IV micafungin versus IV caspofungin for the treatment of esophageal candidiasis
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT03250923 -
CelAgace™ OraRinse Solution for Treatment of Candidiasis
|
Phase 1/Phase 2 | |
| Completed |
NCT00004781 -
Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups
|
N/A | |
| Completed |
NCT03894839 -
Evaluation of the Effect of Different Cleaning and Disinfection Procedures on the Involvement of Candida Species
|
N/A | |
| Completed |
NCT00128323 -
A Comparison of Gentian Violet (GV) Mouth Washes, Nystatin, and Ketoconazole Tabs in Treating Oropharyngeal Candidiasis
|
Phase 3 | |
| Recruiting |
NCT04410250 -
Effect of Oral Hygienization in Newborn on Candida Spp Colonization
|
N/A | |
| Completed |
NCT02184351 -
Clotrimazole vs. Mycelex® in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Oropharyngeal Candidiasis
|
Phase 3 | |
| Recruiting |
NCT03873753 -
Relationship Between Oral Hygiene in Newborns and Candida Spp.
|
N/A | |
| Completed |
NCT02818803 -
Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic
|
Phase 3 | |
| Active, not recruiting |
NCT06120816 -
Nitric Oxide Releasing Mouthwash (NORM) for the Management of Oropharyngeal Candidiasis
|
Phase 1 | |
| Completed |
NCT00235053 -
Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg BID
|
Phase 4 | |
| Completed |
NCT00666185 -
Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis
|
Phase 3 | |
| Completed |
NCT00002446 -
Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients
|
Phase 3 | |
| Completed |
NCT00001448 -
The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV Infection
|
N/A | |
| Completed |
NCT00612963 -
Novel Rinse to Treat in Oral Candidiasis in Cancer Patients
|
N/A | |
| Completed |
NCT00001812 -
A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2
|
Phase 3 | |
| Completed |
NCT00002394 -
Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment
|
N/A | |
| Completed |
NCT00002057 -
Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC
|
N/A | |
| Completed |
NCT00002133 -
An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.
|
N/A | |
| Completed |
NCT00002341 -
A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Success With Itraconazole But Not With Fluconazole
|
N/A | |
| Completed |
NCT00002293 -
A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes
|
N/A |